no desc

Proven efficacy of the Micronized Purified Flavonoid Fraction (MPFF) on chronic venous edema in the recent Vein Act Program-PRO-C3 study.

In this perspective, an observational study conducted in Russia, 708 Chronic Venous Disease (CVD) patients at C3 CEAP stage were involved to assess the effectiveness of different treatments on edema, CVD symptoms, and quality of life of the patients.

no desc

To know more: Click here

It can also interest you

Article

January 14, 2022
Chronic Venous Insufficiency, Cardiovascular Disease and Mortality
Venous disease

Article

January 10, 2022
Efficacy of Micronized Purified Flavonoid Fraction (MPFF) based venoactive ther…
Venous disease

Article

January 7, 2022
The "self-treatment of wounds for venous leg ulcers checklist“ – Do you know th…
Venous disease
Background Vimeo Live Event

Keep up to date with our content

Subscribe to our newsletter so that you are always up to date with the news.

You can unsubscribe at any time by clicking on the link in our emails.
Logo
SERVIER CENTRAL AMERICA AND THE CARIBBEAN, S.A.Edificio Dream Plaza, Costa Del Este, Ciudad de Panamá, Panamá+507-301-0227Todo el contenido de este sitio web, es sólo para los profesionales de la salud y un uso interno del evento.
LogoCopyright © 2022 Servier University by SERVIER CENTRO AMÉRICA Y EL CARIBE, S.A.